{

Case Analysis on BIOCON

KIRAN MAZUMDAR SHAW’S ENTREPRENEURIAL DREAM

ByHarish (2t3-08)Sai Sowjanya(2t3-17)J.Ramya (2t3-20) Agasthia (22005)Jyothilakshmi (220-15)Shruthi(220-76)Adithya(220-95)

INTRODUCTION Chairperson and CEO of Biocon Ltd, India’s

largest Biotechnology company. Born on March 23, 1953 Schooling at Bishop Cotton Girls School

and Mount Carmel College, Bangalore B.Sc. in Zoology from Bangalore

University in 1973 Ballarat University in Melbourne,

Australia and qualified as a master brewer.

Awarded honorary doctorates from University of Abertay, Dundee, U.K. (2007), University of Glasgow, U.K. (2008) and Heriot-Watt University, Edinburgh, U.K. (2008)

Trainee brewer in Carlton & United Beverages in 1974

Became India’s first Brew Master

Switch of occupation

Trainee Manager with Biocon Biochemical Limited in Ireland

in 1978

Founded Biocon India in collaboration with Biocon

Biochemical Limited

HER CAREER

Problem Solver  Adaptability  Personal Responsibility Taker  Empirical Optimism  Resourcefulness  Endurance  Insight  Humility  Awareness  Confidence  Decisiveness  Personable  Intelligence  Effective Communicator 

Prerequisites Of A Successful Entrepreneur

Glass CeilingDEFINITION:A glass ceiling is a political term used to describe "the unseen, yet unbreachable barrier that keeps minorities and women from rising to the upper rungs of the corporate ladder, regardless of their qualifications or achievements.“• The Indian corporate has been largely male dominated, women have been 

able to make a mark, but not at the same speed as is seen in the rest of the world.

•  In India, only about 25 percent of the business leadership comprises women. Whereas when compared to other countries, women comprise nearly 60 percent of the business leadership.

•  Women get so accustomed to their existing job role, which prevents them from reaching the top level. 

• Moreover the organization also has a feeling that it is not worth investing in because, they would get married, have a baby and quit. 

• The challenges might continue to exist, but there is no doubt that a greater representation of women at the workplace is vital today.

Women like Kiran Mazumdar Shaw (CEO of Biocon, India), Ekta Kapoor, Joint Managing Director and Creative Director of Balaji Telefilms , Swati A. Piramal, Vice Chairperson of Piramal Life Sciences and others of their ilk rub shoulders with men in board rooms and are continuously proving that women are and can be as successful as men.

REASON’S FOR BIOCON’S SUCCESS

• No, that was not only the reason for her success.

• The ability to attract and motivate good people was a key

factor behind Biocon’s success.

• People were hand picked by kiran Mazumdar, they grew with

the company and could not think of working for any other

company.

• Biocon has entrepreneurship ,drive ,and scientific talent in

abundance.

Biocon emerged as an integrated biotechnology enterprise with presence in biopharmaceuticals, enzymes , custom research , clinical research.

Biocon was India’s largest biotechnology company in terms of revenues.

The partnership with Cuban institute CIMAB results to launch the India’s first anti-cancer drug (BIOMAB-EGFR).

CHALLENGES FACED

Personal challenges

Youthful age

Gender

Unfamiliar business

Lack of funds/ assets

Infrastructure

Quality

Managing investors expectations

BIOTECHNOLOGY INDUSTRY IN INDIA Biotechnology  has  transformed  many  parts  of  the  chemical 

industry, agriculture and medicine. The  consumption of biotech products  in  India was expected    to 

quadruple within a decade. The  human  and  animal  segment  of  the  industry  alone  was 

growing by at least 20%. In 1999, Indian Biotech Industry  contributes to 1.5% of the global 

biotech industry. In  India  800  Companies  were  operating  in  all  sectors  of 

biotechnology, but only 25 were working  in the modern biotech sectors.

ADVANTAGES OF BIOTECH INDUSTRY IN INDIA

Rich Bio-diversityVaried Species of flora and fauna.Varied climatic zones.Large population and varied demography.Largest agriculture sector.World class information technology. Vast pool of talented and skilled man power. English as the accepted business language. Lower operational costs and technologies.

Increasing Government support for bio technology industry. Government  is  implementing  a  national  Biotechnology Development  Strategy  (NBDS)  and establishing a national Biotechnology Regulatory Authority (NBRA) .

100% FDI in biotechnology sector. Special tax benefits

India had proved its competency in selected areas of biotechnology such as bioprocess engineering ,skills in gene manipulation of microbes and animal cells, capacity in downstream processing and isolation methods, and its competence in recombinant DNA technology of plants and animals.

Kiran  Mzumdar  Shaw  steered  the  company  through  several reinventions, first moving from being an enzymes maker to stains and when prices crashed & chinese competition  intensified, she shifted  focus  to bio-pharma. Now she  is  focusing on  three main businesses-Biocon,  Syngene  &  Clinigene  and  the  company  as  a major biopharma company.

Kiran Mazumdar Shaw  is aware  that  the  real opportunity  lies  in the US and Western Europe, where hundred of billions of dollar are  spent  on  pharmaceuticals  every  year.  However  she  also realizes  that  such  markets  are  difficult  to  enter  as  regulatory charges  are  high  and  there  are  many  large  competitors,  much larger than Biocon.

PERSONALITYHigh self esteem

Loves and believes in herself Tradition and culture

High on conscientiousness Reliable Responsible Organized Dependable

High on agreeableness Warm with employees, stakeholders Trust

High on emotional stability Positive emotional stability

Transformational LeadershipBehavior: Count on every one to give best. Transform teams even under unfavorable conditions Serve as role model How this works: By pursuing innovation with strategic actions. Motivate group by strengthening team optimism and commitment also enthusiasm.

THANK YOU